Abstract

Brown adipose tissue (BAT) dissipates energy to produce heat. Thus, it has the potential to regulate body temperature by thermogenesis. For the last decade, BAT has been in the spotlight due to its rediscovery in adult humans. This is evidenced by over a hundred clinical trials that are currently registered to target BAT as a therapeutic tool in the treatment of metabolic diseases, such as obesity or diabetes. The goal of most of these trials is to activate the BAT thermogenic program via several approaches such as adrenergic stimulation, natriuretic peptides, retinoids, capsinoids, thyroid hormones, or glucocorticoids. However, the impact of BAT activation on total body energy consumption and the potential effect on weight loss is still limited. Other studies have focused on increasing the mass of thermogenic BAT. This can be relevant in obesity, where the activity and abundance of BAT have been shown to be drastically reduced. The aim of this review is to describe pathological processes associated with obesity that may influence the correct differentiation of BAT, such as catecholamine resistance, inflammation, oxidative stress, and endoplasmic reticulum stress. This will shed light on the thermogenic potential of BAT as a therapeutic approach to target obesity-induced metabolic diseases.

Highlights

  • Mechanisms of Impaired Brown Adipose Tissue Recruitment in ObesityBrown adipose tissue (BAT) has been in the spotlight due to its rediscovery in adult humans

  • Reviewed by: Rosalba Senese, Università degli Studi della Campania Luigi Vanvitelli, Italy Radhika Muzumdar, University of Pittsburgh, United States

  • The aim of this review is to describe pathological processes associated with obesity that may influence the correct differentiation of Brown adipose tissue (BAT), such as catecholamine resistance, inflammation, oxidative stress, and endoplasmic reticulum stress

Read more

Summary

Mechanisms of Impaired Brown Adipose Tissue Recruitment in Obesity

BAT has been in the spotlight due to its rediscovery in adult humans This is evidenced by over a hundred clinical trials that are currently registered to target BAT as a therapeutic tool in the treatment of metabolic diseases, such as obesity or diabetes. The aim of this review is to describe pathological processes associated with obesity that may influence the correct differentiation of BAT, such as catecholamine resistance, inflammation, oxidative stress, and endoplasmic reticulum stress. This will shed light on the thermogenic potential of BAT as a therapeutic approach to target obesity-induced metabolic diseases.

BROWN ADIPOSE TISSUE AND OBESITY
BAT ORIGIN AND DIFFERENTIATION
BAT QUANTIFICATION IN HUMANS
MECHANISMS INVOLVED IN BAT EXPANSION
Oxidative Stress
Endoplasmic Reticulum Stress
CONCLUSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.